Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

Mexico - Mexico Delayed Price. Currency in MXN
14.12-0.17 (-1.19%)
At close: 01:59PM CST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close14.29
Open14.20
Bid14.10 x 50000
Ask14.17 x 194200
Day's Range14.00 - 14.21
52 Week Range12.56 - 19.39
Volume1,823,407
Avg. Volume2,952,275
Market Cap13.619B
Beta (5Y Monthly)0.62
PE Ratio (TTM)9.67
EPS (TTM)1.46
Earnings DateOct 24, 2023 - Oct 30, 2023
Forward Dividend & Yield0.77 (5.42%)
Ex-Dividend DateSep 28, 2023
1y Target Est20.93
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LABB.MX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      GENOMMA LAB INTERNACIONAL ANNOUNCES FIFTH DIVIDEND PAYMENT

      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.196080 Mexican pesos per share on its common stock representing a total amount of $ 200,001,600.00 M.N. (two hundred million one thousand and six hu

    • PR Newswire

      GENOMMA LAB INTERNACIONAL INFORMS THE VOLUNTARILY PREPAYMENT OF THE SECOND TRANCHE OF ITS IFC SECURED LOAN

      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announced that on August 04, 2023 it has voluntarily prepaid the total amortization for the second tranche of its IFC secured loan.

    • PR Newswire

      GENOMMA LAB MANUFACTURING FACILITY GRANTED COFEPRIS OPERATING LICENSE FOR ALL ITS PHARMA / OTC MANUFACTURING LINES

      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks ("COFEPRIS") has granted its approval of the sanitary license for the oral liquids, topical liquids and tablet coatings operations at Genomma Lab's Medicinas y Medicamentos Nacionales

    Advertisement
    Advertisement